Simplex Trading’s Apogee Therapeutics APGE Stock Holding History

Simplex Trading’s Portfolio APGE Stock Details APGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-10,700	Closed	-$1.42M	–	9170
2026 Q2	$1.42M	Buy	10,700 +4,600	+75%	+$414K	﹤0.01%	2388
2026 Q1	$513K	Buy	6,100 +1,500	+33%	+$109K	﹤0.01%	3229
2025 Q4	$347K	Sell	4,600 -7,100	-61%	-$447K	﹤0.01%	3675
2025 Q3	$464K	Sell	11,700 -7,000	-37%	-$267K	﹤0.01%	3922
2025 Q2	$812K	Buy	18,700 +12,200	+188%	+$464K	﹤0.01%	2991
2025 Q1	$242K	Buy	+6,500	New	+$251K	﹤0.01%	4117
2024 Q4	–	Sell	-200	Closed	-$11K	–	8436
2024 Q3	$11K	Buy	+200	New	+$9.6K	﹤0.01%	7103

Other funds holding APGE

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Simplex Trading's APGE Position: Q3 2026 in Review

Simplex Trading sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 2,368 shares — an estimated $314K sold.

Simplex Trading first reported a position in APGE in Q3 2024 and held it in 5 quarters. The position peaked at $6.55M in Q1 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.

Simplex Trading reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
Simplex Trading sold 2,368 Apogee Therapeutics shares in Q3 2026, an estimated $314K.
Simplex Trading first reported a position in Apogee Therapeutics in Q3 2024 and held it in 5 quarters.
Simplex Trading's Apogee Therapeutics position peaked at $6.55M in Q1 2026.
2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.